1. How hard it is to clone a human.
Last year, a Korean team became the first to clone a human embryo, coaxing it to the blastocyst stage at which embryonic stem cells can be obtained.
ILLUSTRATION: JUNE HSU
In August last year, a team from the UK was given the first British license to perform therapeutic cloning for human embryos, with a further license granted to Professor Ian Wilmut's team at the Roslin Institute.
Even with this sort of expertise, stem cell expert Dr Steven Minger of King's College London does not expect success this year, "it's going to be very difficult."
Meanwhile, although cloning of primates has succeeded in Pittsburgh, it appears that all attempts at implantation have failed.
2. More about Titan.
A few hours' worth of information could be all scientists get for 20 years of endeavor as Huygens, the dinner table-sized probe of the Cassini spacecraft, parachuted through the atmosphere of Titan Friday.
But what information? Titan is the mystery moon of Saturn. Its opaque, smoggy, orange atmosphere means that its surface has never been seen before. "By next week, we could have a completely different view of another world in our solar system," says TV science presenter Dr Chris Riley. "It may be the last time in history that we'll be able to say that."
Titan is a world dominated by constantly reacting organic compounds with lakes, or even oceans, of liquid ethane, methane and nitrogen.
3. What it's like inside a comet
Deep impact is a six-year NASA mission to discover what lies deep inside a comet. Like Cassini, this is two spacecraft in one -- a flyby craft and a smaller impactor.
In July, in a piece of spectacular cosmic vandalism, the impactor will be launched directly into the path of comet Tempel 1 for a "planned collision," forming a crater 14 storeys deep and a football stadium wide, all of which will be filmed by the onboard camera.
"Comets are time capsules that hold clues about the formation and evolution of the solar system," says NASA. If they find complex molecules, rather than the simple ones anticipated, expect the history of Earth to be rapidly rewritten in 2005.
4. How someone looks after a face transplant.
A surgical team from Louisville, Kentucky, is hotly tipped to perform the world's first face transplant this year, taking a face from a donor corpse and attaching it to a severely disfigured recipient.
The team, which includes bioethicists, submitted a detailed proposal to an ethics panel last May, and the lengthy approvals process concludes soon. In Britain, meanwhile, plans have been put on hold after a Royal College of Surgeons' working party concluded that the risks outweighed the benefits.
5. Whether the world's oceans are becoming more acidic and what it means for wildlife.
The UK's Royal Society's working party on rising acidity of oceans reports in the spring. Environmental biologist professor John Raven, who is chairing it, says: "The same pollution that we believe is heating the world's oceans through global warming is also altering its chemical balance."
Of particular concern is the impact of rising acidity on ocean creatures needing calcium carbonate for their structure, such as corals and molluscs. It might also affect plankton and have a potentially disastrous consequence on marine food webs.
6. Whether carbon trading works.
Carbon trading, a key plank of the Kyoto agreement, began two weeks ago but, like much to do with Kyoto, already seems to be going nowhere.
Countries rushed in ill-thought proposals to meet the January deadline. Dr Keith Tovey, the HSBC director of low carbon innovation at the University of East Anglia (UEA) in southeast England, points out what will happen if the EU approves the plans of the defaulting nations (Poland, Czech Republic, Italy and Greece).
"They've set their allocations so high that if approved, it will affect the price of carbon credits, causing them to plummet." And at a stroke, the whole scheme descends into farce.
It's not all bad on the global warming front. Tovey's colleague at the Carbon Reduction Center at UEA, Dr Trevor Davies, predicts that by the end of the year, "the combination of science certainty and increasing extreme climate events will have won over more of the doubters and persuaded those already converted of the need for urgent action."
7. How effective biometric ID data is (and whether it prevents terrorism).
High-tech passports containing biometric data are to be introduced in Britain next year, five years ahead of the international deadline, so that the UK can remain in the US visa waiver program.
This requires passports with embedded electronic chips containing a log of up to 1,800 facial characteristics which can be compared electronically to those held on an international database.
Failure rates of up to 10 percent have already been reported in the technology and there are doubts that the system it will do much more than validate the honest.
8. Whether RNAi is hype or hope.
RNA interference (RNAi) has been hyped as the greatest medical advance since antibiotics.
"By the end of 2005, we'll have a much better idea of whether it's likely to be a potential treatment or will be a research tool up there with PCR (polymerase chain reaction -- a way of creating multiple copies of DNA)," says Dr Richard Sullivan, director of clinical programs at Cancer Research UK.
RNAi is a naturally occurring defense system triggered by double stranded RNA (typical of many viruses) entering the cell. RNAi blocks specific genes and prevents them from working.
Harnessing this "silencing" phenomena could allow disease-causing genes to be switched off at will. It is already being trialed in prostate and cervical cancer but the first report of a trial, on the eye disease AMD, is due at the end of the year.
9. Whether artificial life is a flash in the pan or a new industry.
"Vesicle bioreactors" are the Scrapheap Challenge of biology. A crude artificial cell, they have walls made from fats in egg white and contain the contents of an E coli cell stripped of its genes, plus a virus enzyme to decode DNA.
Distinctly unpromising -- yet when genes are added, they dutifully churn out proteins just like normal cells would. These are the recently announced brainchild of Albert Lichlaber at Rockefeller University. They could be the early entrants to a new field, synthetic biology, in which entire organisms are built from scratch.
Life? Not as we know it, Jim.
What we still won't know
Whether nuclear is an option.
It is an election year in Britain, so discussion of the nuclear option in relation to climate change could be inhibited, despite the fact that renewables cannot possibly produce the carbon reductions needed to comply with Kyoto.
How to clone a baby.
The expert Pittsburgh group failed to get a single cloned monkey embryo to implant. Treat any human claims from Zavos, Antinori and their ilk this year with extreme suspicion.
The whereabouts of the Higgs Boson particle.
Better concealed than a snowflake in a blizzard, this puppy is highly unlikely to reveal itself, even if it exists outside the fevered imaginations of particle physicists.
An endless source of energy.
Wonderful idea, but cold fusion, whether it involves a glass of water, a cup of tea or even a jug of Tizer, is not going to happen this year. Or ever?
The biological purpose of a female orgasm.
If an orgasm is not necessary for conception, what is the point of it?
Why women go into labor.
With more than 750,000 births a year in Britain alone, you'd have thought someone would have cracked this mystery.
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
The past few months have seen tremendous strides in India’s journey to develop a vibrant semiconductor and electronics ecosystem. The nation’s established prowess in information technology (IT) has earned it much-needed revenue and prestige across the globe. Now, through the convergence of engineering talent, supportive government policies, an expanding market and technologically adaptive entrepreneurship, India is striving to become part of global electronics and semiconductor supply chains. Indian Prime Minister Narendra Modi’s Vision of “Make in India” and “Design in India” has been the guiding force behind the government’s incentive schemes that span skilling, design, fabrication, assembly, testing and packaging, and
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.